Listening to Challenges of Killer Regulations in the Bio Industry
The Korea Technology Finance Corporation (hereinafter referred to as Kibo) announced that Chairman Kim Jong-ho visited BioComplet (CEO Heo Jae-eok), located in Guro-gu, Seoul, on the 30th to listen to the key regulatory challenges in the bio industry and discuss regulatory improvement measures aligned with global standards.
BioComplet is a specialized company in bio clinical trial research and analysis, holding numerous patents related to protein commercialization. It is an excellent technology-based small and medium enterprise growing annually through research and development (R&D) commercialization. Kibo evaluated the technological value of patents related to protein commercialization and supported their commercialization. Additionally, Kibo has continuously provided various products suitable for all stages of corporate growth, including R&D development funds and working capital.
Chairman Kim toured the R&D facilities with CEO Heo Jae-eok and stated, "Kibo will provide focused support through customized products so that advanced technology companies in ultra-gap fields can scale up and leap to become global top-tier companies." He added, "Furthermore, we will actively work to resolve regulations in advanced strategic industries to comply with the global standard principle led by the government."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
